Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana

References

• Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ. Management and outcome of bacille Calmette Guerin vaccine adverse reactions. Vaccine. 2015;33:5470–8. doi:10.1016/j.vaccine.2015.07.103.
   PubMed Web of Science ®Google Scholar
• Lauring AS, Jones JO, Andino R. Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol. 2010;28(6):573–9. doi:10.1038/nbt.1635.
   PubMed Web of Science ®Google Scholar
• Covian C, Fernandez-Fierro A, Retamal-Diaz A, Diaz FE, Vasquez AE, Lay MK, Riedel CA, Gonzalez PA, Bueno SM, Kalergis AM. BCG-induced cross protection and development of trained immunity: implications for vaccine design. Front Immunol. 2019;10:2806. doi:10.3389/fimmu.2019.02806.
   PubMed Web of Science ®Google Scholar
• Jeena PM, Chagan MK, Topley J, Coovadia HM. Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa. Bull World Health Organizan. 2001;79:337–43.
   PubMed Web of Science ®Google Scholar
• Sellami K, Amouri M, Kmiha S, Bahloul E, Aloulou H, Sfaihi L, Guirat R, Mseddi M, Kamoun T, Hachicha M, et al. Adverse reactions due to the bacillus Calmette-Guerin Vaccine: twenty Tunisian cases. Indian J Dermatol. 2018;63(1):62–5. doi:10.4103/ijd.IJD_327_17.
   PubMed Web of Science ®Google Scholar
• Goraya J, Virdi V. Bacille Calmette-Guerin lymphadenitis. Postgrad Med J. 2002;78(920):327–9. doi:10.1136/pmj.78.920.327.
   PubMed Web of Science ®Google Scholar
• McNeil MM, Weintraub ES, Duffy J, Sukumaran L, Jacobsen SJ, Klein NP, Hambidge SJ, Lee GM, Jackson LA, Irvin SA, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016;137(3):868–78. doi:10.1016/j.jaci.2015.07.048.
   PubMed Web of Science ®Google Scholar
• Lei J, Balakrishnan MR, Gidudu JF, Zuber PLF. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015. Vaccine. 2018;36(12):1577–82. doi:10.1016/j.vaccine.2018.02.012.
   PubMed Web of Science ®Google Scholar
• Cabral D. A guide to contraindications to childhood vaccinations. Can J Infect Dis. 2000;11:13–14.
   PubMedGoogle Scholar
• Chahal D, Aleshin M, Turegano M, Chiu M, Worswick S. Vaccine-induced toxic epidermal necrolysis: a case and systematic review. Dermatol Online J. 2018;24:13030/QN5268s.
   PubMedGoogle Scholar
• Arvas A. Vaccination in patients with immunosuppression. Turk Pediatri Ars. 2014;49(3):181–5. doi:10.5152/tpa.2014.2206.
   PubMedGoogle Scholar
• Hawkridge T, Scriba TJ, Gelderbloem S, Smit E, Tameris M, Moyo S, Smit E, Tameris M, Moyo S, Lang T, et al. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis. 2008;198:544–52. doi:10.1086/590185.
   PubMed Web of Science ®Google Scholar
• Jeena PM, Chhagan MK, Topley J, Coovadia HM. Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa. Bull World Health Organ. 2001;79:337–43.
   PubMed Web of Science ®Google Scholar
• Roxo-Junior, Silva J, Andrea M, Oliveria L, Ramalho F, Bezerra T. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of primary immunodeficiency. Ital J Pediatr. 2013;39:54. doi:10.1186/1824-7288-39-54.
   PubMed Web of Science ®Google Scholar
• Yamoah P, Bangalee V, Oosthuizen F. A review of the safety of vaccines used in routine immunization in Africa. Afr Health Sci. 2020;20(1):227–37. doi:10.4314/ahs.v20i1.28.
   PubMed Web of Science ®Google Scholar
• Raosoft sample size calculator by Raosoft, Inc. http://www.raosoft.com/samplesize.html
   Google Scholar
• Masika CW, Atieli H, Were T. Knowledge, perceptions, and practice of nurses on surveillance of adverse events following childhood immunization in Nairobi, Kenya. Biomed Res Int. 2016;2016:3745298. doi:10.1155/2016/3745298.
   PubMed Web of Science ®Google Scholar
• Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol. 2005;5:37. doi:10.1186/1471-2288-5-37.
   PubMedGoogle Scholar
• deMeyrick J. The Delphi method and health research. Health Educ. 2003;103(1):7–16. doi:10.1108/09654280310459112.
   Google Scholar
• Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
   Google Scholar
• World Health Organization. Global manual on surveillance of adverse events following immunization [Internet]. Geneva: WHO. 2016 http://apps.who.int/iris/bitstream/10665/206144/1/9789241507769.
   Google Scholar
• Piot P, Larson HJ, O’Brien KL, N’kengasong J, Ng E, Sow S, Kampmann B. Immunization: vital progress, unfinished agenda. Nature. 2019;575(7781):119–29. doi:10.1038/s41586-019-1656-7.
   PubMed Web of Science ®Google Scholar
• Feyisa D, Ejeta F, Aferu T, Kebede O. Adherence to WHO vaccine storage codes and vaccine cold chain management practices at primary healthcare facilities in Dalocha District of Silt’e Zone, Ethiopia. Trop Dis Travel Med Vaccines. 2022;8:10. doi:10.1186/s40794-022-00167-5.
   PubMedGoogle Scholar
• Hesse EM, Hibbs BF, Cano MV. Notes from the Field: administration of expired injectable influenza vaccines reported to the vaccine adverse event reporting system-United States, July 2018-March 2019. MMWR. 2019;68(23):529–30. doi:10.15585/mmwr.mm6823a3.
   PubMed Web of Science ®Google Scholar
• Biering-Sorensen S, Andersen A, Ravn H, Monterio I, Aaby P, Benn CS. Early BCG vaccine to low birth in infants and the effects on growth in the first year of life: a randomized controlled trial. BMC Pediatr. 2015;15:37. doi:10.1186/s12887-015-0452-2.
   PubMed Web of Science ®Google Scholar
• Vadalà M, Poddighe D, Laurino C, Palmieri B. Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? Epma J. 2017;8(3):295–311. doi:10.1007/s13167-017-0101-y.
   PubMed Web of Science ®Google Scholar
• Whitaker JA, Ovsyannikova IG, Poland GA. Adversomics: a new paradigm for vaccine safety and design. Expert Rev Vaccines. 2015;14(7):935–47. doi:10.1586/14760584.2015.1038249.
   PubMed Web of Science ®Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM. Adversomics: the emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J. 2009;28(5):431–2. doi:10.1097/INF.0b013e3181a6a511.
   PubMed Web of Science ®Google Scholar
• Hu Y, Li Q, Lin L, Chen E, Chen Y, Qi X. Surveillance of adverse events following immunization from 2008 to 2011 in Zhejiang province, China. Clini Vaccine Immunol. 2013;20(2):211–7. doi:10.1128/CVI.00541-12.
   PubMedGoogle Scholar
• World Health Organization. Safety of BCG Vaccines. Extract from report of GACVS meeting of 7-8 June 2017, published in the WHO weekly Epidemiological record of 14 July 2017. https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/bcg-vaccines.
   Google Scholar
• Laryea EB, Frimpong JA, Noora CL, Tengey J, Bandoh D, Sabblah G, Ameme D, Kenu E, Amponsa-Achiano K. Evaluation of the adverse events following immunization surveillance in Ghana, 2019. Plos One. 2022;17(3):e0264697. doi:10.1371/journal.pone.0264697.
   PubMed Web of Science ®Google Scholar
• Mohammed LA, Aliyu AA, Maiha BB, Isa A. Knowledge, perceptions and reporting attitude of adverse effects following immunization among primary healthcare workers in Sabon Gari local government area Zaria, Kaduna State, Nigeria. Niger J Basic Clin Sci. 2018;15:81–6. doi:10.4103/njbcs.njbcs_18_17.
   Google Scholar
• Mehmeti I, Nelaj E, Simaku A, Tomini E, Bino S. Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania. Heliyon. 2017;3:e00331. doi:10.1016/j.heliyon.2017.e00331.
   PubMedGoogle Scholar
• Hutchinson P, Nelson M, Hill S, Duran L, Engler R. Knowledge, attitude and beliefs (KAB) regarding reporting of adverse events following immunization (AEFI). J Allergy Clin Immunol. 2007;119:S96. doi:10.1016/j.jaci.2006.11.594.
   Web of Science ®Google Scholar
• Cassidy C, MacDonald NE, Steenbeek A, Ortiz JR, Zuber PL, Top KA. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants. Hum Vaccines Immunother. 2016;12(8):2010–6. doi:10.1080/21645515.2016.1175697.
   PubMed Web of Science ®Google Scholar
• Parrella A, BraunackMayer A, Gold M, Marshall H, Baghurst P. Health care providers’ knowledge, experience and challenges of reporting adverse events following immunization: a qualitative study. BMC Health Serv Res. 2013;13:313. doi:10.1186/1472-6963-13-313.
   PubMed Web of Science ®Google Scholar
• Musa OI, Parakoyi DB, Akanbi AA. Evaluation of health education intervention on safe immunization injection among health workers in Ilorin, Nigeria. Ann Afr Med. 2006;5:122128.
   Google Scholar